ScolioLife CEO named UN representative to ECOSOC group

By AI, Created 9:46 AM UTC, May 20, 2026, /AGP/ – ScolioLife said founder and CEO Dr. Kevin Lau has been appointed as a United Nations representative to the Africana Women Working Group at ECOSOC for 2026. The role gives Lau access to UN policy forums as the clinic pushes for broader recognition of scoliosis screening and non-surgical treatment.

Why it matters: - Dr. Kevin Lau now has a formal platform inside the UN system to push scoliosis screening and non-surgical correction into global health discussions. - The appointment could help advance policy arguments for earlier detection, school-based screening, and wider reimbursement or subsidy support in Asia. - ScolioLife is using the role to elevate scoliosis from a clinic-level issue to a public health issue with policy implications.

What happened: - ScolioLife announced that CEO and founder Dr. Kevin Lau was appointed as a United Nations representative to the Africana Women Working Group at the UN Economic and Social Council for 2026. - The appointment runs from April 1 through Dec. 31, 2026. - Lau will represent the AWWG ECOSOC NGO in UN processes, including the ECOSOC Youth Forum, the Commission on the Status of Women, the Commission on Social Development, the Commission on Population and Development, and the UN High-Level Political Forum on Sustainable Development. - Lau is authorized to contribute to policy dialogues, statements and reports, and to apply to host parallel or side events at UN sessions.

The details: - ScolioLife said ECOSOC forums are where governments, civil society organizations and health bodies help shape national health policy, research priorities and disability classification standards. - The company said those frameworks affect access for an estimated 80% of adolescent scoliosis cases worldwide that go undetected until surgery or lifelong bracing is needed. - Scoliosis affects an estimated 2% to 3% of the global population, or about 165 million people. - In Asia, studies across Singapore, Malaysia and Indonesia show scoliosis screening rates below World Health Organization benchmarks for early detection. - The condition has no dedicated global health resolution, no internationally standardized early screening protocol and no place in UN Sustainable Development Goal health metrics. - In Southeast Asia, surgery for progressive scoliosis commonly costs SGD 60,000 to SGD 120,000. - The company said early non-surgical correction can reduce curves at a fraction of that cost. - Lau said the appointment gives the team a seat at the table where scoliosis policy can change.

Between the lines: - The appointment appears to be part advocacy win, part strategic positioning for ScolioLife in a policy arena that can influence clinical standards and funding decisions. - The UN role may also strengthen the clinic’s case for recognition of the ScolioLife Method, which combines the ScolioAlign brace with customized exercises. - In Indonesia, where ScolioLife operates a Surabaya clinic, the lack of a national school screening mandate leaves many families learning about scoliosis only after curves exceed 40 degrees, the surgical threshold. - Lau said his ECOSOC work will focus on equity-of-access issues in lower-income populations across ASEAN.

What’s next: - Lau plans to use the UN platform to advocate for mandatory adolescent scoliosis screening in school health programs. - He also aims to push for non-surgical scoliosis correction to be included in national healthcare subsidy frameworks. - ScolioLife wants the ScolioLife Method recognized as an evidence-based clinical standard. - Lau’s appointment follows a recent role on the Forttuna Health and Wellness Council, signaling continued international engagement around health advocacy.

The bottom line: - ScolioLife is turning a clinical appointment into a policy opportunity, betting that UN access can help move scoliosis screening and non-surgical care higher on the global health agenda.